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ABSTRACT 
Preterm infants are at increased risk for developing bronchopulmonary dysplasia 
(BPD). BPD is characterized by impaired lung development, with decreased lung 
compliance and increased lung tissue resistance. Decreased airway resistance is a related 
complication. Male infants typically experience worse outcomes of BPD than female 
infants and have a higher risk for acquiring the disease. BPD is induced by poor lung 
development, mechanical ventilation, and postnatal growth restriction (PGR) related to 
feeding complications. Poor feeding can result in limited consumption of specific 
nutrients essential to lung development, including docosahexaenoic acid (DHA). 
Decreased circulating DHA levels have been found in preterm infants who develop BPD. 
However, outcomes from clinical studies examining the effects of postnatal DHA 
supplementation on BPD outcomes are conflicting. 
DHA is a ligand for the transcriptional regulator peroxisome proliferator-activated 
receptor gamma (PPARg), a nuclear receptor transcription factor that contributes to lung 
development. The SET-domain containing histone methyltransferase (Setd8) is a 
transcriptional target of PPARg in the lung, and serves as a useful downstream parameter 
for assessing PPARg activity. We hypothesize that postnatal DHA supplementation will 
have a dose- and sex-dependent impact on lung function and structure, lung PPARg and 
Setd8 protein, and Setd8 expression, and circulating fatty acids in the juvenile rat. 
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To test our hypothesis, we induced PGR in Sprague Dawley rat pups and 
observed the effect of high (0.1%), low (0.01%), and no DHA (0.0%) supplementation 
compared to age- and sex-matched controls. Lung function was measured through tissue 
compliance, tissue damping, and airway resistance. PPARg and Setd8 mRNA transcript 
and protein levels were measured in lung homogenate. Sex-divergent outcomes were 
found in PPARg protein, Setd8 protein, and tissue damping. DHA was found to 
ameliorate the impact of PGR in all functional tests, with females showing greater 
sensitivity to DHA in restoration of compliance.  
In conclusion, DHA causes sex- and dose-dependent changes in lung function and 
lung PPARγ levels in PGR rat pups. We speculate that sex-divergent responses to DHA 
reflect sex-divergent metabolism of DHA. We further speculate that sex-divergent effects 
of PGR on lung mechanics may reflect differences in the structural organization and 
composition of the lung.  
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INTRODUCTION 
Bronchopulmonary Dysplasia and Postnatal Growth Restriction 
Bronchopulmonary dysplasia (BPD) affects 10,000 preterm infants in the United 
States each year.1 BPD, the chronic lung disease of early infancy, results in high 
mortality and increased risk of comorbidities for premature infants. Survivors often suffer 
long-term consequences, including deficits in lung health over the lifetime.  
Preterm birth influences the development of BPD through several mechanisms. 
Weeks 28-32 of gestation are a critical period for lung development.2 Consequently, the 
lungs of preterm infants, typically born at 28 to 32 weeks gestational age, are 
underdeveloped. Furthermore, preterm infants usually require respiratory support. While 
necessary for survival, respiratory support exposes the infants to a hyperoxic breathing 
environment, which induces further manifestation of BPD.3 Mechanical ventilation, one 
common form of respiratory support, has the additional drawback of interfering with 
preterm infant feedings, which in turn influences the development of BPD.4 Male infants 
typically experience worse outcomes of BPD than female infants and have a higher risk 
for acquiring the disease.5 
Feeding complications related to mechanical ventilation, or other comorbidities of 
preterm birth, put preterm infants at greater risk for postnatal growth restriction (PGR). 
PGR is generally defined as “…a weight less than the 10th percentile for corrected 
gestational age at the time of hospital discharge.”6 The sedation required for mechanical 
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feeding often contributes to severe caloric deficits in preterm infants, who are also prone 
to feeding intolerance and critical illness, further impeding their ability to consume 
sufficient nutrients. These factors combine to induce PGR and augment the presentation 
of BPD.6,7 
Sex-divergent Effects of PGR on Lung Function 
BPD augmented by PGR impacts several aspects of lung function. The disease is 
characterized by impaired lung development, with decreased lung compliance and 
increased lung tissue resistance.8 Decreased airway resistance is a related complication.9 
Preliminary work by our lab indicates that these conditions display sex-divergent 
phenotypes, with males being at higher risk of increased lung tissue damping and females 
being at a higher risk for increased airway resistance, with both sexes showing similar 
risk for decreased lung compliance. 
DHA and Lung Function 
Docosahexaenoic acid (DHA), an Omega-3 (w-3) long chain polyunsaturated 
fatty acid (PUFA), has been shown to affect fetal lung development.10,11,12 Altered levels 
of circulating fatty acids, including decreased DHA, have been found in preterm infants 
who develop BPD.13 Significantly, DHA is a ligand for the transcriptional regulator 
peroxisome proliferator-activated receptor gamma (PPARg).14 Nutrient activation by 
ligands such as DHA is essential to lung development. However, outcomes from clinical 
studies examining the effects of postnatal DHA supplementation on BPD outcomes are 
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conflicting. As a result, consensus on dose and sex effects of DHA supplementation in 
human PGR infants is lacking.  
As previously stated, in rats, PGR causes sex-divergent deficits in lung function. 
The effects of PGR on circulating DHA, and the impact of postnatal supplementation 
with DHA, are also sex-divergent. Previous work by our lab shows that PGR decreases 
circulating DHA in male rats, but not female rats. These differences present a potential 
avenue for refining the administration of DHA and maximizing its benefit to the preterm 
infant with BPD.  
PPARg and Lung Function 
PPARg is a member of the PPAR family of nuclear receptors. As a group, they are 
involved in many important regulatory pathways, including fat metabolism, cell 
differentiation and proliferation, and inflammation.15 There are two isoforms of the 
PPARg gene, PPARg1 and PPARg2, produced with different transcriptional starting 
points. Both isoforms are expressed in the lung and are required for lung development.12 
PPARg ligands, including DHA, activate both isoforms. DHA has displayed a higher 
binding affinity for PPARg compared to other long chain fatty acids.16 This knowledge 
makes PPARg a prime target of study for the treatment of infant lung disease, 
specifically, BPD.  
As with the development of BPD and the impact of DHA supplementation, 
PPARg expression in the lung differs by sex. Previous work by our lab demonstrated that 
PPARg expression is higher in male rat pups without PGR than female rat pups without 
PGR, whereas PGR decreases that expression in males but not in females.17 
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Setd8 
The SET-domain containing histone methyltransferase (Setd8) functions as an 
epigenetic modifier and as such can affect gene expression. It places a monomethyl (Me) 
group on lysine (K) 20 of Histone (H) 4, and is one transcriptional target of PPARg.18 
PPARg is, in turn, a target of Setd8 activity. In our rat model of intrauterine growth 
restriction, we demonstrated that intrauterine growth restriction (IUGR) decreased protein 
levels of lung PPARγ and Setd8 independent of gender, with outcomes normalized by 
maternal DHA.12 The same study indicated that levels of the Setd8-dependent histone 
modification, H4K20Me, were reduced on the PPARγ gene in rat pups with intrauterine 
growth restriction, representing a possible feedback loop through epigenetic 
modification. Because of this relationship, Setd8 serves as a useful downstream 
parameter for assessing PPARg activity. 
Hypothesis 
We hypothesize that postnatal DHA supplementation will have a dose- and sex-





PGR was induced in Sprague Dawley rat pups using variation in litter size.1 
Newborn rat pups were cross-fostered to rat dams with litter sizes of 16 (PGR) or 8 
(control). Each litter was randomized to receive diets supplemented with DHA at 0.0%, 
0.01%, and 0.1%. Rat pup weight was measured every other day from day of life 0 (d0) 
to d21. At d21, control and PGR rat offspring were euthanized using a sodium 
pentobarbital overdose. At d21, serum and lung tissue were collected and immediately 
flash frozen in liquid nitrogen.  
DHA Supplementation 
Pregnant rats were fed either standard rodent chow or a custom diet containing 
0.01% or 0.1% DHA. The custom diets were based on Harlen Teklad 8640 standard 
rodent diet (TD.8640, Harlan-Teklad, WI), substituting 0.01% and 0.1% DHA for 0.01% 
and 0.1% of the standard soybean oil, respectively. All other macronutrient content was 
maintained compared to standard rodent chow (21.8% protein, 40.8% carbohydrate, and 
5.4% fat, with a caloric density of 3 Kcal/g). The pregnant rats were fed one of the three 
diets from E13 until term. Food intake was independent of diet. 
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Measurements of Lung Mechanics 
The mechanical properties of the PGR and control rat lungs on regular and both 
DHA diets were measured using the FlexiVent system (Scireq, Canada). Rats were 
anesthetized, paralyzed, and ventilated. 
We measured static lung compliance, as well as tissue damping and airway 
resistance.  
mRNA and Protein Analysis 
PPARg and Setd8 mRNA transcript levels were measured in lung homogenate 
from PGR and control rat lungs on regular and both DHA diets using real-time reverse 
transcriptase PCR, with the following Assay on Demand: PPARg Rn01492274_m1 
(Thermo Fischer Scientific), and Setd8 Rn01477383_g1 (Thermo Fisher Scientific). 
PPARg and Setd8 protein abundance were measured using Western blotting. The primary 
antibody used was PPARg (B5) (Santa Cruz, TX). GAPDH was used as a housekeeping 
gene for RT PCR and Western blotting.  
Statistical Analysis 
PGR rat pups were compared to sex-matched control pups. Male and female rats 
were considered separate groups. Sample size was n=4-20 per group. GraphPad Prism 
was used for statistical analysis. One-way ANOVA with post hoc test was used to detect 
differences between groups. Statistical significance was defined as p<0.05.  
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RESULTS 
Growth of Rat Pups 
In both female and male rat pups, body weight of PGR pups was significantly less 
than sex-matched control by postnatal day 5, and continued to be significantly less 
through postnatal day 21, with the magnitude of growth restriction comparable in both 
male and female rat pups. Body weights of PGR rat pups are not affected by either DHA 
diet (see Figure 1). 
Lung Mechanics 
In male rats, PGR decreased lung compliance. Lung compliance remained 
significantly less than control levels with the 0.01% diet, but was not significantly 
different on the 0.1% diet (see Figure 2). In female rats, PGR also decreased lung 
compliance. However, lung compliance was restored to control levels by both the 0.01% 
and 0.1% DHA diet (see Figure 3).  
In male rats, PGR increased tissue damping. No statistical difference in tissue 
damping was found between the control on regular diet and the PGR pups on either DHA 
diet (see Figure 4). In female rats, neither PGR nor DHA supplementation affected tissue 
damping (see Figure 5).  
In male rats, PGR increased airway resistance, with restoration by both DHA diets 
(see Figure 6). Likewise, airway resistance was increased by PGR in female rats, and 
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normalized by both DHA doses (see Figure 7). 
PPARg Results 
Both PPARg mRNA variants were measured as both have been shown to play a 
role in lung development. In males, PGR decreased PPARg1 mRNA levels. Levels were 
further decreased by supplementation with both the 0.01% DHA diet and the 0.1% DHA 
diet (see Figure 8). PPARg1 mRNA levels were not affected significantly by PGR in 
females, but similar to males were reduced by both DHA diets (see Figure 9). Similarly 
to PPARg1, PGR reduced PPARg2 mRNA levels in males, with further reductions by 
DHA supplementation (see Figure 10). PPARg2 mRNA levels in females likewise 
followed the same pattern as seen in PPARg1, with no reduction evident from PGR, but 
with depressed levels by DHA supplementation (see Figure 11). 
PPARg protein levels were reduced by PGR in males, but not in females. The low 
DHA diet did not change protein levels significantly from PGR pups on a regular diet, 
but restoration to normal levels was seen with the high dose of DHA. No significant 
changes in PPARg protein levels were seen in females from any of the interventions (see 
Figures 12 and 13). 
Setd8 Results 
Changes in Setd8 mRNA levels followed the same pattern in males as in females. 
PGR increased Setd8 levels, while both doses of DHA restored levels to normal, with no 
significant difference between doses (see Figures 14 and 15). In male pups, Setd8 protein 
levels were increased significantly by PGR. Both doses of DHA supplementation further 
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increased protein levels, with no significant difference between doses (see Figure 16). In 
female pups, no significant differences were observed between the control and PGR 
infants on regular or DHA diets (see Figure 17). 
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Figure 1. Growth curves of control rat pups on regular diet and PGR rat pups on regular, 
0.01%, and 0.1% DHA diet 
Growth of PGR rat pups was significantly less than control among both males and 
females and was unaffected by DHA supplementation (n=9-20; *p<0.05). Control rat 
pups are represented with the solid black and red lines, and PGR rat pups with the dashed 
black and red lines. The green and orange lines on each growth curve show the PGR rats 
receiving 0.01% and 0.1% DHA diet, respectively. 
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Figure 2. Static lung compliance of male control rat pups on regular diet and male PGR 
rat pups on regular, 0.01%, and 0.1% DHA diet 
Lung compliance of male rat pups was significantly reduced by PGR and restored to 
normal levels by a high dose of DHA supplementation (n=5-12; *p<0.05). 
Figure 3. Static lung compliance of female control rat pups on regular diet and female 
PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
Lung compliance of female rat pups was significantly reduced by PGR and restored to 
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Figure 4. Tissue damping of male control rat pups on regular diet and male PGR rat pups 
on regular, 0.01%, and 0.1% DHA diet 
Tissue damping of male rat pups was significantly increased by PGR and restored to 
normal levels by a low dose of DHA supplementation (n=4-12; *p<0.05). 
Figure 5. Tissue damping of female control rat pups on regular diet and female PGR rat 
pups on regular, 0.01%, and 0.1% DHA diet 
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Figure 6. Airway resistance of male control rat pups on regular diet and male PGR rat 
pups on regular, 0.01%, and 0.1% DHA diet 
Airway resistance of male rat pups was increased by PGR and restored to normal levels 
by a low dose of DHA supplementation (n=4-13; *p<0.05). 
Figure 7. Airway resistance of female control rat pups on regular diet and female PGR rat 
pups on regular, 0.01%, and 0.1% DHA diet 
Airway resistance of female rat pups was increased by PGR and restored to normal levels 
by a low dose of DHA supplementation (n=4-11; *p<0.05 compared to control on regular 
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Figure 8. PPARg1 mRNA transcript levels in male control rat pups on regular diet and 
male PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg1 mRNA transcript levels in male rat pups were significantly reduced by PGR, 
and again by a low dose of DHA supplementation (n=6-7; *p<0.05 compared to control 
on regular diet; ^p<0.05 compared to PGR on regular diet). 
Figure 9. PPARg1 mRNA transcript levels in female control rat pups on regular diet and 
female PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg1 mRNA transcript levels in female rat pups were not changed significantly by 
PGR, and significantly reduced by a low dose of DHA supplementation (n=6-7; *p<0.05 


















M a le  P P A R g 1  m R N A
P P A R g 1  m R N A























F e m a le  P P A R g 1  m R N A
P P A R g 1  m R N A





Figure 10. PPARg2 mRNA transcript levels in male control rat pups on regular diet and 
male PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg2 mRNA transcript levels in male rat pups were significantly reduced by PGR, 
and again by a low dose of DHA supplementation (n=6; *p<0.05 compared to control on 
regular diet; ^p<0.05 compared to PGR on regular diet). 
Figure 11. PPARg2 mRNA transcript levels in female control rat pups on regular diet and 
female PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg2 mRNA transcript levels in female rat pups were not changed significantly by 
PGR, and significantly reduced by a low dose of DHA supplementation (n=5-6; *p<0.05 
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Figure 12. PPARg protein levels in male control rat pups on regular diet and male PGR 
rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg protein levels in male rat pups were significantly reduced by PGR and restored to 
normal levels by a high dose of DHA supplementation (n=6; *p<0.05). 
Figure 13. PPARg protein levels in female control rat pups on regular diet and female 
PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
PPARg protein levels in female rat pups were not significantly altered either by PGR or 
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Figure 14. Setd8 mRNA transcript levels in male control rat pups on regular diet and 
male PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
Setd8 mRNA transcript levels in male rat pups were significantly increased by PGR and 
restored to normal levels by a low dose of DHA supplementation (n=6-8; *p<0.05 
compared to control on regular diet; ^p<0.05 compared to PGR on regular diet). 
Figure 15. Setd8 mRNA transcript levels in female control rat pups on regular diet and 
female PGR rat pups on regular, 0.01%, and 0.1% DHA diet 
Setd8 mRNA transcript levels in female rat pups were significantly increased by PGR 
and restored to normal levels by a low dose of DHA supplementation (n=6-8; *p<0.05 
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Figure 16. Setd8 protein levels in male control rat pups on regular diet and male PGR rat 
pups on regular, 0.01%, and 0.1% DHA diet 
Setd8 protein levels in male rat pups were significantly increased by PGR and again by a 
low dose of DHA supplementation (n=6; *p<0.05 compared to control on regular diet; 
^p<0.05 compared to PGR on regular diet). 
Figure 17. Setd8 protein levels in female control rat pups on regular diet and female PGR 
rat pups on regular, 0.01%, and 0.1% DHA diet 
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DISCUSSION 
As a treatment for BPD, DHA has shown clinical promise, and its relevance is 
widely accepted in the field of neonatal pulmonology. The third trimester is a time of 
significant DHA accrual in fetal tissue, and because of this, supplemental DHA may play 
an especially beneficial role for preterm infants.19 The idea that DHA may be important 
for lung development began with the observation that circulating DHA levels were 
decreased in preterm infants who develop BPD.13 
One possible mechanism for the impact of DHA on lung development is its 
interaction with the nuclear transcription factor PPARg. When activated by a ligand, this 
nuclear receptor protein plays many important roles in the lung, including maintaining 
lipid homeostasis, mediating intercellular communication, and regulating epigenetic 
enzymes, including Setd8.12,15 PPARg is well known to influence BPD outcomes through 
mediation of alveolar homeostasis, and treatment with PPARg agonists appears to 
effectively ameliorate aspects of BPD pathogenesis.20 DHA has been shown to activate 
and possess a high binding affinity for both isoforms of PPARg.16,21 The potential benefit 
of DHA to infant lung development may work, at least in part, through this mechanism.  
Supplemental DHA in preterm infants has been shown to improve lung 
architecture and responses to respiratory challenges.10 On the other hand, the same 
research suggests longer and more frequent apneas consequent to w-3 supplementation. 
Furthermore, a recent study showed that enteral DHA supplementation did not result in a 
20 
lower risk of BPD than a control emulsion among preterm infants born before 29 weeks 
of gestation and may have resulted in a greater risk.22 
These latter findings call into question the appropriateness of supplemental DHA 
in acute care for preterm infants. However, in that study, dosage was standardized at 60 
mg/kg/day and no distinction based on sex was made in the analysis. Previous work by 
our lab shows that circulating essential fatty acids, including DHA, are altered by PGR in 
a sex-divergent fashion, suggesting that response to DHA supplementation may vary by 
sex.17 Our current study aimed to interrogate the role of both sex and dose in outcomes 
for supplemental DHA. We found that DHA supplementation restored all functional 
outcomes to control levels in both male and female PGR pups, lending further support to 
its potential as an intervention for BPD. We hypothesized that the impact of DHA 
supplementation would differ between sexes, and a sex-divergent response was observed 
in PPARg protein, Setd8 protein, lung tissue compliance, and tissue damping.  
We likewise found that DHA had the anticipated impact on PPARg protein levels. 
BPD affects male infants more severely than it does female infants, and PGR magnifies 
those symptoms. Given this background, the reduction in PPARg in male rat pups 
consequent to PGR, and the lack thereof in female rat pups, is not surprising. The 
restoration of PPARg protein levels by DHA further reinforces its potential benefit to 
infants with BPD.  
In correspondence with the trend seen in PPARg protein, we observed that PGR 
decreases PPARg mRNA in males but not females. However, the decrease in PPARg 
mRNA with DHA contrasts sharply with the restoration seen in PPARg protein and 





PPARg, DHA may play a role in increasing the efficiency of protein that has already been 
translated, thereby diminishing the need to transcribe more copies of the gene and 
causing it to be downregulated. This notion is reinforced by the restoration of PPARg 
protein levels in males despite the continuing decrease in mRNA levels, suggesting that 
the restorative mechanism is not increased transcription, but rather preservation of the 
protein once it has been transcribed.  
Setd8 was chosen as a molecular marker for PPARg activity in this study because 
it has already been shown to be a target of PPARg in the lung.18 Activated PPARg 
protein, functioning in its role as a transcription factor, binds to a PPAR response element 
– a sequence of nucleotides in the target gene recognized by PPARg – and initiates 
transcription of Setd8. Setd8, in turn, places a methyl group on histone proteins 
associated with other genes, among them PPARg, thereby altering their expression. 
Through this means, PPARg can mediate the epigenetic environment of the cell. 
 Based on our knowledge of this pathway, we would expect that as PPARg protein 
decreased in males in response to PGR, Setd8 mRNA would also be decreased, and as 
PPARg protein remained constant in females, so would Setd8 mRNA. Contrary to our 
hypothesis, however, Setd8 mRNA increased in both males and females, and its response 
to DHA supplementation bears no association with that of PPARg protein. It is not clear 
to us at this time why Setd8 did not show a direct response to PPARg. Compared to our 
work in IUGR, which showed an increase in Setd8 mRNA corresponding with PPARg, 
this opposite effect may reflect different compensatory mechanisms at work in utero 
versus ex utero. In utero, the fetus still has access to maternal nutrient stores and other 
forms of support. Once outside, the offspring as an organism is on its own, and may 
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compensate by downregulating or upregulating different pathways than it would with full 
access to maternal resources. Based on the significant changes in Setd8 mRNA in 
response to supplementation, however, we can surmise that DHA may influence Setd8 
transcription through a means other than PPARg.  
The functional outcomes tell a similar story. Despite their congruence with the 
field, our PPARg-related findings do not correspond with all functional outcomes 
measured in this study and have implications for the mechanistic involvement of PPARg. 
Since airway resistance was increased by PGR in both sexes and restored in both by a 
low dose of DHA, while PPARg was significantly reduced only in males, we may assume 
that PPARg is not the mechanism behind the development of this phenotype. We 
speculate that airway resistance may be driven by inflammatory mediators, independent 
of PPARg, which respond to DHA.  
Similar to airway resistance, lung compliance was altered in both sexes, and 
restored by supplemental DHA. Here again, it seems unlikely that PPARg was part of 
either the pathogenic or restorative pathways. Nevertheless, the results for lung 
compliance support our hypothesis that supplemental DHA would have sex-divergent 
outcomes. While restoration was seen in both sexes, in females, restoration was seen at a 
low dose, whereas males did not return to normal until the high dose, suggesting a greater 
sensitivity to DHA among female rat pups. This reinforces the notion that dosage 
considerations should be made when providing DHA supplementation in acute care 
settings.  
Of the three functional outcomes measured, tissue damping is the only one to 





but not females and its restoration by DHA is inversely associated with the trend in 
PPARg protein levels, suggesting that PPARg may be involved in creating the normal 
phenotype. While normalcy in PPARg protein levels lagged behind restoration in tissue 
damping, this does not rule out the possibility that PPARg plays a mechanistic role in the 
pathway if less than normal levels are required for restoration.  
If PPARg is involved in the increase in tissue damping, it may be acting through 
alterations in elastin deposition. Tissue damping reflects the energy dissipation in the 
alveoli, or what is known as tissue viscoelasticity. Semireflective of resistance to 
pressure, tissue damping also incorporates the speed at which the tissue will expand 
under a given pressure. This property is most likely related to the structural composition 
of the tissue, including the arrangement of elastin. Elastin, a component of alveolar walls, 
forms fiber-like structures through a process known as crosslinking. PPARg has been 
shown to alter elastin deposition in the neonatal rat lung.23 Additionally, work by our lab 
shows that the expression of elastin in the developing rat lung is altered by IUGR.24 Other 
studies have found that alternative splicing of elastin can affect elastin crosslinking and 
modify disease severity.25 Changes in alternative splicing and elastin crosslinking and 
deposition may be a factor in increasing tissue damping. We speculate that PPARg may 
be involved in the process of alternative splicing and thereby modify the level of tissue 
damping. Future studies will involve measurement of elastin alternative splicing and 
assessment of elastin deposition and crosslinking and the influence of supplemental DHA 
thereon, in combination with a PPARg inhibitor to identify or rule out its involvement.  
 There are limitations to this study. There are many factors that could shape the 
impact of DHA supplementation that were not assessed in this study, including the 
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developmental window of administration. While we speculate that DHA is operating 
through PPARg in some cases and in others not, this supposition is based on association. 
Although DHA is a known activator of PPARg, it is also known to impact macrophage 
polymerization and to influence inflammation as a precursor to eicosanoids and could 
potentially shape phenotype through these mechanisms.26 To verify the pathway, future 
tests would involve administration of a PPARg antagonist and observing whether or not 
the results remained intact.  
In conclusion, DHA causes sex- and dose-dependent changes in lung function and 
lung PPARγ levels in PGR rat pups. We speculate that sex-divergent responses to DHA 
reflect sex-divergent metabolism of DHA. We further speculate that sex-divergent effects 
of PGR on lung mechanics may reflect differences in the structural organization and 
composition of the lung.  
This study sheds light on the importance of dose and sex considerations in 
postnatal DHA supplementation. While much work has been done to investigate the 
relationship of DHA supplementation on the mechanisms of preterm infant lung 
development and the mechanistic role of PPARg, work examining the divergent 
outcomes in males and females is limited. Identifying specific responses between the 
sexes furthers the development of more appropriate dosage recommendations for 
differing male and female physiologies. Though many beneficial outcomes for infants 
with BPD have been reported with DHA supplementation, other reports suggest a 
potentially harmful effect in some cases. Sex-adjusted dosages may be the key to 
maximizing the benefit of DHA supplementation for this population while avoiding any 
potential harm.  
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